> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Changes Date of Panel Meeting
- URL: https://www.fdaweb.com/fda-changes-date-of-panel-meeting/
- Published: 2016-04-06T12:00:00.000Z
- Updated: 2026-09-14T20:53:03.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5135298

*Federal Register* Notice: FDA is amending a notice of a meeting of the Endocrinologic and Metabolic Drugs Advisory Committee announced in the 3/17 Federal Register. The date of the meeting is changed to from 5/25 to 5/24\. The committee will discuss the safety and efficacy of a Novo Nordisk NDA for insulin degludec and liraglutide injection for the proposed indication: adjunct to diet and exercise to improve glycemic control in treating adults with Type 2 diabetes mellitus. Contact **LaToya Bonner**, (301) 796-9001\. To view this notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2016-04-06/pdf/2016-07906.pdf?ref=fdaweb.com).